Next Article in Journal
Unveiling the Function of the Mitochondrial Filament-Forming Protein LACTB in Lipid Metabolism and Cancer
Next Article in Special Issue
Hashimoto Encephalopathy—Still More Questions than Answers
Previous Article in Journal
Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates
Previous Article in Special Issue
Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 11
Issue 10
10.3390/cells11101700
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cells 2022, 11(6), 942.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942

by
Anna Zakrzewicz
1,
Celina Würth
1,
Benedikt Beckert
1,
Simon Feldhoff
1,
Katrien Vanderheyden
2,
Stian Foss
3,4,
Jan Terje Andersen
3,4,
Hans de Haard
2,
Peter Verheesen
2,
Vladimir Bobkov
2 and
Ritva Tikkanen
1,*
1
Institute of Biochemistry, Medical Faculty, University of Giessen, Friedrichstrasse 24, 35392 Giessen, Germany
2
Argenx BV, Industriepark Zwijnaarde 7, 9052 Ghent, Belgium
3
Department of Immunology, University of Oslo and Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway
4
Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway
*
Author to whom correspondence should be addressed.
Cells 2022, 11(10), 1700; https://doi.org/10.3390/cells11101700
Submission received: 17 May 2022 / Accepted: 18 May 2022 / Published: 20 May 2022
(This article belongs to the Special Issue Autoimmune Diseases: Molecular Mechanisms and Therapies)
Versions Notes
The authors wish to make the following changes to their paper [1]. Figure 4 should be replaced. In the original publication, there was a mistake in Figure 4a as published. One of the images showing the monolayer dissociation assay examples was accidentally duplicated (Fc-WT + hAK23 and Fc-IHH + hAK23 were duplicated). We have now replaced Fc-WT + hAK23 with the correct image. The corrected Figure 4 appears below.
Cells 11 01700 i001
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Zakrzewicz, A.; Würth, C.; Beckert, B.; Feldhoff, S.; Vanderheyden, K.; Foss, S.; Andersen, J.T.; de Haard, H.; Verheesen, P.; Bobkov, V.; Tikkanen, R. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zakrzewicz, A.; Würth, C.; Beckert, B.; Feldhoff, S.; Vanderheyden, K.; Foss, S.; Andersen, J.T.; Haard, H.d.; Verheesen, P.; Bobkov, V.; et al. Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942. Cells 2022, 11, 1700. https://doi.org/10.3390/cells11101700

AMA Style

Zakrzewicz A, Würth C, Beckert B, Feldhoff S, Vanderheyden K, Foss S, Andersen JT, Haard Hd, Verheesen P, Bobkov V, et al. Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942. Cells. 2022; 11(10):1700. https://doi.org/10.3390/cells11101700

Chicago/Turabian Style

Zakrzewicz, Anna, Celina Würth, Benedikt Beckert, Simon Feldhoff, Katrien Vanderheyden, Stian Foss, Jan Terje Andersen, Hans de Haard, Peter Verheesen, Vladimir Bobkov, and et al. 2022. "Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942" Cells 11, no. 10: 1700. https://doi.org/10.3390/cells11101700

APA Style

Zakrzewicz, A., Würth, C., Beckert, B., Feldhoff, S., Vanderheyden, K., Foss, S., Andersen, J. T., Haard, H. d., Verheesen, P., Bobkov, V., & Tikkanen, R. (2022). Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942. Cells, 11(10), 1700. https://doi.org/10.3390/cells11101700

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop